Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038454 (
stroke
)
147,016
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although metabolic syndrome has been recognized as a risk factor for ischemic
stroke
, genetic factors associated with ischemic
stroke
in individuals with metabolic syndrome remain unknown. We examined an association of genetic variants with ischemic
stroke
among individuals with or without metabolic syndrome. The study population comprised 4,387 unrelated Japanese individuals, including 1,884 individuals with metabolic syndrome (240 subjects with ischemic
stroke
and 1,644 controls) and 2,503 individuals without metabolic syndrome (280 subjects with ischemic
stroke
and 2,223 controls). The 150 polymorphisms examined in the present study were selected by genome-wide association studies of ischemic
stroke
and myocardial infarction with the use of the GeneChip Human Mapping 500K Array Set (Affymetrix). The initial chi-square test revealed that the Cright curved arrow T polymorphism (rs9925481) of CLEC16A and the Aright curved arrow G polymorphism (rs4923918) of
SPTBN5
were significantly (P<0.005) associated with ischemic
stroke
among individuals with metabolic syndrome. No polymorphism was significantly associated with ischemic
stroke
among individuals without metabolic syndrome. Multivariable logistic regression analysis with adjustment for covariates and a stepwise forward selection procedure revealed that the Aright curved arrow G polymorphism (rs4923918) of
SPTBN5
was significantly (P<0.005), and the Cright curved arrow T polymorphism (rs9925481) of CLEC16A was almost significantly, associated with ischemic
stroke
in individuals with metabolic syndrome. Genetic variants that confer susceptibility to ischemic
stroke
may differ among individuals with or without metabolic syndrome. Stratification of subjects according to the presence or absence of metabolic syndrome may thus be important for personalized prevention of ischemic
stroke
based on genetic information.
...
PMID:Association of genetic variants with ischemic stroke in Japanese individuals with or without metabolic syndrome. 2004 39